Engineering and Technology

Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges

R. P. Singh, A. Natarajan, et al.

Discover how the innovative fusion of nanoparticles and artificial intelligence is revolutionizing targeted drug delivery in cancer therapy! This review by Ravindra Pratap Singh, Arunadevi Natarajan, Deepak Kumar, Kaushik Pratim Das, and Chandra J explores the promising advances and challenges in making chemotherapy more effective and personalized.

00:00

Playback language: English

Index

Abstract

This review highlights the convergence of nanoparticles (NPs) and artificial intelligence (AI) for targeted drug delivery in cancer therapy. It discusses the advantages and challenges of using NPs for drug delivery, focusing on overcoming limitations of conventional chemotherapy like poor bioavailability and non-specific targeting. The review emphasizes the role of AI in addressing these challenges, including biomarker detection, prediction of NP-drug interactions, and optimization of drug efficacy. While acknowledging the limited research specifically on this convergence, the study aims to showcase recent advances and future potential in personalized cancer treatment.

Publisher

Frontiers in Medical Technology

Published On

Jan 06, 2023

Authors

Ravindra Pratap Singh, Arunadevi Natarajan, Deepak Kumar, Kaushik Pratim Das, Chandra J

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Ligand-switchable nanoparticles resembling viral surface for sequential drug delivery and improved oral insulin therapy

T. Yang, A. Wang, et al.

Medicine and Health

The Impact of Targeted Treatment and Mass Drug Administration Delivery Strategies on the Prevalence and Intensity of Schistosomiasis in School Aged Children in Africa: A Systematic Review

N. Chanhanga, T. Mindu, et al.

Medicine and Health

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours

H. K. Tang, C. Tang, et al.

Medicine and Health

Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy

J. Yi, O. Tavana, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny